UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000033961
Receipt No. R000038737
Scientific Title Effectiveness and safety of Combination therapy of Ranibizumab and LuseOgliflozin in type 2 diabetes with diabetic Macular Edema, a parallel group comparison with the standard Treatment controlled by Glimepiride, multicenter, randomized, open-label trial. (COMET Trial)
Date of disclosure of the study information 2018/08/30
Last modified on 2019/03/04 18:17:30

No. Disposal Last modified on Item of update
1 Insert 2018/08/30 19:31:50
2 Update 2018/08/30 19:36:54 Key secondary outcomes
3 Update 2018/09/04 09:47:32 Key secondary outcomes
Key secondary outcomes
4 Update 2018/09/04 10:52:15 Key exclusion criteria
Key exclusion criteria
5 Update 2019/03/04 18:17:30 Recruitment status

Contact us.